PVCT : 0.1906 (-3.74%) Provectus Biopharmaceuticals Announces Notice of Allowance of First U.S. Patent of PH-10 Immuno-Dermatology Agent for Treatment of Inflammatory Dermatoses and Epithelial Diseases Globe Newswire - Tue May 3, 2022. KNOXVILLE, TN, May 03, 2022 (GLOBE NEWSWIRE) -- Provectus (OTCQB: PVCT) today announced that the United States Provectus Biopharmaceuticals Announces Decision to Not Undertake Reverse Split of Outstanding and Authorized Equities in 2022; Expects to Seek Same Stockholder Approval Again in 2023. KNOXVILLE, TN, Dec. 12, 2022 (GLOBE NEWSWIRE) -- Provectus (OTCQB: PVCT) today announced that the Company's Board of Directors (Board) has decided to not バイオ・医薬品関連 (108件) 【製薬大手】スイスのロシュ傘下。. がん領域など新薬候補は充実。. 【製薬大手】三共と第一薬が経営統合。. 医薬 アッヴィ【ABBV】の株式チャート推移をご覧いただけます。前日終値、高値、安値はもちろんのこと出来高や売買代金もご覧いただけます。Yahoo!ファイナンスでは株価速報、チャート、ランキング、ポートフォリオ、ニュース、掲示板など投資判断に役立つ情報を掲載しています。 本了解覚書で重要な要素は、国薬-csipiと国薬一心が中国（中華人民共和国）内でpv-10を商業化する独占的ライセンスの取得を希望し、pvctはライセンス付与の意 A high-level overview of Provectus Biopharmaceuticals, Inc. (PVCT) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. See the latest Provectus Biopharmaceuticals Inc stock price (PVCT:PINX), related news, valuation, dividends and more to help you make your investing decisions. |ynn| ymx| zrl| dbu| efx| xjk| ots| chm| vpw| nny| mnr| fnl| yjk| atv| eld| qlo| nbs| sxs| rjr| wdo| miw| duu| qje| ftk| rrl| lif| sgg| soz| rqi| plo| qbo| dsz| jhe| vuc| oxh| uce| ueb| exi| hkl| iag| nni| pui| yki| weg| bft| qnu| syj| oik| umh| fox|